Page last updated: 2024-12-06

1-methylhydantoin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1-Methylhydantoin is a heterocyclic compound that has been studied for its potential applications in various fields. It can be synthesized through different methods, including the reaction of hydantoin with methyl iodide. Research has shown that 1-methylhydantoin exhibits biological activity and may possess properties relevant to areas such as medicine, agriculture, and materials science. Its potential uses are still under investigation, and further research is necessary to fully understand its properties and applications.'

1-methylhydantoin: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID69217
CHEMBL ID4758352
CHEBI ID16354
SCHEMBL ID21769
MeSH IDM0100303

Synonyms (48)

Synonym
CHEBI:16354
1-methylimidazolidine-2,4-dione
2,4-imidazolidinedione, 1-methyl-
nsc-80560
nsc80560
616-04-6
dioxy-creatinine
1-methylhydantoin
hydantoin, 1-methyl-
C02565
n-methylhydantoin ,
n-methylimidazolidine-2,4-dione
1-methylhydantoin, 97%
63EB0A26-EFB8-4972-8359-66A71ED3C67D
1-methyl-hydantoin
rhybfkmfhlpqph-uhfffaoysa-
inchi=1/c4h6n2o2/c1-6-2-3(7)5-4(6)8/h2h2,1h3,(h,5,7,8)
M1027
STK801997
AKOS000119438
0546h9ur1r ,
einecs 210-460-6
unii-0546h9ur1r
1-methyldiazolidine-2,4-dione
nsc 80560
FT-0632575
SCHEMBL21769
PS-4018
methylhydantoine
methylhydantoin
1-methyl hydantoin
1-methylimidazolidin-2,4-dione
STR08386
AC-34375
1-methyl-2,4-imidazolidinedione #
DTXSID90210595
mfcd00003187
1-methyl-2,4-imidazolidinedione
CS-0062340
HY-113382
Q27101864
EN300-19234
AT20200
S6184
bdbm50549806
chembl4758352 ,
SY057100
Z104473250

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" The present study was designed to explore the toxic effect of 1-methylhydantoin on renal proximal tubular cells in vitro."( 1-Methylhydantoin cytotoxicity on renal proximal tubular cells in vitro.
Jiang, YS; Li, CZ; Liu, D; Liu, FY; Peng, YM; Yang, B, 2007
)
2.02
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
bacterial metaboliteAny prokaryotic metabolite produced during a metabolic reaction in bacteria.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
imidazolidine-2,4-dioneAn imidazolidinone with oxo groups at position 2 and 4.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (2)

PathwayProteinsCompounds
creatinine degradation II327
Urea cycle and metabolism of amino groups2116

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Protein cereblonHomo sapiens (human)IC50 (µMol)137.00000.28601.70663.0000AID1685005
Protein cereblonHomo sapiens (human)Ki67.80001.49006.580010.0000AID1685005
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (7)

Processvia Protein(s)Taxonomy
protein ubiquitinationProtein cereblonHomo sapiens (human)
positive regulation of Wnt signaling pathwayProtein cereblonHomo sapiens (human)
negative regulation of protein-containing complex assemblyProtein cereblonHomo sapiens (human)
positive regulation of protein-containing complex assemblyProtein cereblonHomo sapiens (human)
negative regulation of monoatomic ion transmembrane transportProtein cereblonHomo sapiens (human)
locomotory exploration behaviorProtein cereblonHomo sapiens (human)
proteasome-mediated ubiquitin-dependent protein catabolic processProtein cereblonHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (3)

Processvia Protein(s)Taxonomy
protein bindingProtein cereblonHomo sapiens (human)
transmembrane transporter bindingProtein cereblonHomo sapiens (human)
metal ion bindingProtein cereblonHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (6)

Processvia Protein(s)Taxonomy
nucleusProtein cereblonHomo sapiens (human)
cytoplasmProtein cereblonHomo sapiens (human)
cytosolProtein cereblonHomo sapiens (human)
membraneProtein cereblonHomo sapiens (human)
perinuclear region of cytoplasmProtein cereblonHomo sapiens (human)
Cul4A-RING E3 ubiquitin ligase complexProtein cereblonHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1685005Binding affinity to human CRBN-thalidomide binding domain expressed in Escherichia coli by measuring baseline corrected normalized fluorescence by MST based assay2021ACS medicinal chemistry letters, Jan-14, Volume: 12, Issue:1
Sweet and Blind Spots in E3 Ligase Ligand Space Revealed by a Thermophoresis-Based Assay.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (33.33)18.7374
1990's3 (20.00)18.2507
2000's1 (6.67)29.6817
2010's5 (33.33)24.3611
2020's1 (6.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 21.68

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index21.68 (24.57)
Research Supply Index2.77 (2.92)
Research Growth Index5.15 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (21.68)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other15 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]